Immunogenicity and tolerability of atrivalent influenza subunit vaccine (influvac®) in high-risk children aged 6 months to 4 years

International Journal of Clinical Practice

Volumn 51, Issue 2, 1997, Pages 87-90

  Daubeney, P ^a   Taylor, C J ^b,e   McGaw, J ^b   Brown, E M ^a   Ghosal, S ^b   Keeton, B R ^b   Palache, B ^c   Kerstens, R ^d  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c Duphar House   (United Kingdom)

^d Solvay Pharmaceuticals Inc   (Netherlands)

^e SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; INFLUENZA VACCINE;

ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CHRONIC LUNG DISEASE; CLINICAL TRIAL; CONGENITAL HEART DISEASE; COUGHING; ERYTHEMA; FEVER; HIGH RISK PATIENT; HUMAN; IMMUNOGENICITY; INFANT; INFLUENZA; INSOMNIA; INTRAMUSCULAR DRUG ADMINISTRATION; IRRITABILITY; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; SEROCONVERSION;

ANTIBODIES, BACTERIAL; CHILD, PRESCHOOL; FEMALE; HEART DEFECTS, CONGENITAL; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; INFANT; INFLUENZA VACCINES; INFLUENZA, HUMAN; RESPIRATION DISORDERS;

EID: 0030941105     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Glezen WP, Paredes A, Taber LH. Influenza in children: relationship to other respiratory agents. J Am Med Assoc 1980; 243: 1345-1349.
2. Leads from the MMWR. Prevention and Control of Influenza. Pan 1 : vaccines. JAMA 1989; 261: 3220-3227.
3. Gruber WC, Kirschner K, Tollefson S et al. Comparison of monovalent and trivalent live attenuated influenza vaccines in young children. J Infect Dis 1993; 168: 53-60
4. Groothuis JR. Levin MJ, Rabalais GP et al. Immunization of high risk infants younger than 18 months of age with split-product influenza vaccine. Pediatrics 1991; 87: 823-828.
5. World Health Organization. Recommended composition of influenza vaccines for use in the 1994-1995 season. Wkly Epidemiol Rec 1994; 69: 53-60.
6. National Institute for Biological Standards and Control. Standard Operating Procedure on Haemagglutination Inhibition Test for Antibody to Influenza Virus (FLU 13/1). Unpublished, 1993.
7. Commission of the European Communities. The rules governing medicinal products in the European Community, volume 3, addendum 2. Commission European Communities 1992, 93-98
8. Palache AM. Influenza sub-unit vaccine - ten years' experience. Eur J Clin Res 1992; 3: 117-138.
9. Bernstein DI, Zahradnik JM, DeAngelis CJ, Cherry JD. Clinical reactions and serologic responses after vaccination with whole-virus or split-virus influenza vaccines in children aged 6 to 36 months. Pediatrics 1982; 69: 404-408.
10. Adlard P, Bryett K. Influenza immunisation in children with cystic fibrosis. J Int Med Res 1987; 15: 344-351.
11. Heikkinen T, Ruuskanen O, Waris M et al. Influenza vaccination in the prevention of acute otitis media in children. Am J Dis Child 1991; 145:445-458.